Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • US top court rejects...

    US top court rejects Boston Scientific's patent licensing appeal

    Written by supriya kashyap kashyap Published On 2017-02-22T14:18:08+05:30  |  Updated On 22 Feb 2017 2:18 PM IST
    US top court rejects Boston Scientifics patent licensing appeal

    The U.S. Supreme Court turned away an appeal by Boston Scientific Corp of a Maryland state court jury verdict ordering the medical device company to pay $308 million to a patent licensor for breach of contract concerning implantable cardiac devices.


    Boston Scientific had asked the justices to hear its appeal in the dispute over its licenses to patented technology on the implantable devices owned by Mirowski Family Ventures, arguing the Maryland court made mistakes applying patent law, a job typically reserved for federal courts.


    In its lawsuit, Maryland-based Mirowski claimed Massachusetts-based Boston Scientific did not pay all the royalties it owed after acquiring Guidant Corp, which had licensed the patents, and then settling patent infringement litigation involving Guidant.


    The patents related to devices that can correct irregular heart rhythms, preventing cardiac arrest.


    In 2014, a state jury awarded Mirowski about $308 million in royalties and damages for breaching a license agreement. The Maryland Court of Appeals refused to hear the appeal last July.


    Boston Scientific said the judge in the Maryland Circuit Court violated federal precedents by refusing to interpret the meaning of one of the patents, saying the task made him feel "queasy."


    The case illustrates the hazards of relegating highly technical and complex issues of patent law to state courts, Boston Scientific said.


    Mirowski had urged the Supreme Court not to hear the appeal, arguing the state court judge merely adopted the meaning of the patent made by a federal judge in a previous case.

    Bostoncardiac arrestcardiac devicesimplantable cardiac deviceslicensing appealmedical deviceMirowski Family VenturesSupreme Court
    Source : Reuters

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    supriya kashyap kashyap
    supriya kashyap kashyap
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok